Proscia
UnclaimedRewiring pathology for precision medicine through digital solutions and AI.
Visit WebsitePaidVisit Website
Tracked since2026
0 reviews trackedThe Bottom Line
Entry price
Paid plans only
Biggest pro
Accelerates drug development and biomarker discovery
Biggest con
No specific cons mentioned in the provided text.
TL;DR - Proscia
- Digital pathology platform for life sciences and clinical diagnostics.
- Accelerates drug discovery, biomarker development, and diagnostic workflows with AI.
- Improves lab efficiency, diagnostic accuracy, and pathologist experience.
Pricing: Paid only
Best for: Enterprises & pros
What is Proscia?
Proscia offers a comprehensive digital pathology platform, Concentriq, designed to transform pathology workflows from research and development to clinical diagnostics. It provides purpose-built solutions for life sciences (Concentriq LS) to accelerate biomarker discovery and drug development, and for diagnostics (Concentriq AP and FDA-cleared Concentriq AP-Dx) to digitize labs, improve diagnostic quality, and increase efficiency. The platform integrates advanced digitization, AI, and real-world data to enable faster breakthroughs and more precise patient insights.
The platform is utilized by leading academic medical centers, health systems, commercial labs, major CROs, and pharmaceutical companies. Proscia's solutions aim to address challenges like the rising diagnostic burden, pathologist shortages, and the increasing demand for precision medicine by offering intuitive interfaces for interpreting and managing cases, advanced collaboration tools, and AI-powered image analysis. Proscia Aperture, a precision medicine solution, further enhances the platform by turning routine pathology data into actionable, real-time insights, supporting drug development and market access strategies.
Proscia's offerings are designed to accelerate the shift to 100% digital diagnosis, empower data science and AI teams, and enable the development and deployment of AI solutions for both therapy development and precision diagnostics. It focuses on improving the pathologist experience, running more efficient labs, and positioning organizations for future growth in the evolving landscape of digital pathology and AI.
Available on: Web
Pros & Cons
Pros
- Accelerates drug development and biomarker discovery
- Improves diagnostic quality and efficiency in labs
- FDA-cleared solution for primary diagnosis
- Enables seamless collaboration across teams and partners
- Provides real-time, actionable patient insights
Cons
- No specific cons mentioned in the provided text.
Key Features
Concentriq LS for life sciences R&DConcentriq AP for advanced digitization and AI in diagnosticsConcentriq AP-Dx (FDA-cleared) for primary diagnosis and clinical trialsAI portfolio for building and deploying AI solutionsProscia Aperture for real-time, point-of-diagnosis patient insightsAdvanced collaboration tools for image and study sharingAI-powered image analysis workflowsSecure and compliant data management (data integrity and traceability)
Pricing
Paid
Proscia offers paid plans. Visit their website for current pricing details.
Reviews
$99Free with your review
Write a reviewReview Proscia, get a free AI guide
Share your experience and we will send you Improve Your Thinking Patterns Using ChatGPT, free.
Best Proscia Alternatives
Top alternatives based on features, pricing, and user needs.
Still deciding?
Most buyers shortlist 2 or 3 tools before committing. Pull a side-by-side comparison or browse the full alternatives shortlist below.
Explore More
Proscia FAQ
How does Proscia support drug development and biomarker discovery?
Proscia offers Concentriq LS, a purpose-built solution for life sciences that accelerates biomarker discovery and drug development. It integrates advanced digitization, AI, and real-world data to enable faster breakthroughs in therapy development.
Which teams benefit most from Proscia's digital pathology platform?
Proscia's platform is best suited for academic medical centers, health systems, commercial labs, major CROs, and pharmaceutical companies. It empowers data science and AI teams while improving the pathologist experience and lab efficiency.
How does Proscia Concentriq AP-Dx compare to a competitor like iTero?
Proscia Concentriq AP-Dx is an FDA-cleared solution specifically designed for primary diagnosis in digital pathology, aiming to improve diagnostic quality and efficiency in labs. While both operate in healthcare technology, iTero focuses on intraoral scanning for dentistry, representing a different specialization within medical imaging.
Can Proscia help address pathologist shortages and rising diagnostic burdens?
Yes, Proscia's solutions are designed to address challenges like pathologist shortages and the rising diagnostic burden. It provides intuitive interfaces for interpreting and managing cases, advanced collaboration tools, and AI-powered image analysis to increase efficiency.
How is Proscia priced?
Proscia is offered as a paid product. It does not include a permanently free tier for its comprehensive digital pathology platform and AI solutions.
Does Proscia offer solutions for both research and clinical diagnostics?
Yes, Proscia provides solutions for both research and clinical diagnostics. Concentriq LS is for life sciences research, while Concentriq AP and the FDA-cleared Concentriq AP-Dx are designed for clinical diagnostic labs.
What kind of insights does Proscia Aperture provide?
Proscia Aperture is a precision medicine solution that turns routine pathology data into actionable, real-time insights. These insights support drug development and market access strategies by providing deeper understanding from pathology data.
Source: proscia.com